Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Retained Earnings: 2018-2020

Historic Retained Earnings for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $825.6 million.

  • Genmab A's Retained Earnings rose 23.18% to $1,537 in Q2 2023 from the same period last year, while for Jun 2023 it was $1,537, marking a year-over-year increase of 23.18%. This contributed to the annual value of $825.6 million for FY2020, which is 272.72% up from last year.
  • Genmab A's Retained Earnings amounted to $825.6 million in FY2020, which was up 272.72% from $221.5 million recorded in FY2019.
  • Genmab A's Retained Earnings' 5-year high stood at $825.6 million during FY2020, with a 5-year trough of -$21.8 million in FY2018.
  • In the last 3 years, Genmab A's Retained Earnings had a median value of $221.5 million in 2019 and averaged $341.8 million.
  • Data for Genmab A's Retained Earnings shows a peak YoY skyrocketed of 1,114.63% (in 2019) over the last 5 years.
  • Genmab A's Retained Earnings (Yearly) stood at -$21.8 million in 2018, then skyrocketed by 1,114.63% to $221.5 million in 2019, then skyrocketed by 272.72% to $825.6 million in 2020.